LifeMD, Inc.
LFMD
$8.26
$0.101.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.07% | 39.27% | 42.16% | 38.63% | 32.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.07% | 39.27% | 42.16% | 38.63% | 32.85% |
| Cost of Revenue | 45.77% | 27.34% | 13.52% | 12.62% | 9.36% |
| Gross Profit | 42.71% | 40.96% | 46.42% | 42.73% | 36.78% |
| SG&A Expenses | 30.98% | 36.93% | 38.24% | 32.54% | 18.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 31.82% | 45.65% | 47.04% | 32.52% | 5.58% |
| Total Operating Expenses | 33.12% | 36.86% | 37.04% | 31.64% | 18.89% |
| Operating Income | 58.27% | -11.43% | -0.83% | 10.30% | 39.50% |
| Income Before Tax | 52.66% | -5.26% | 16.67% | 22.28% | 40.80% |
| Income Tax Expenses | -6.07% | -6.07% | 83.12% | 18.66% | 18.66% |
| Earnings from Continuing Operations | 51.71% | -4.99% | 15.30% | 21.76% | 40.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 75.52% | 94.44% | 87.65% | 18.60% | -118.81% |
| Net Income | 54.06% | 8.32% | 21.85% | 21.56% | 35.56% |
| EBIT | 58.27% | -11.43% | -0.83% | 10.30% | 39.50% |
| EBITDA | 64.67% | -10.22% | 0.15% | 10.99% | 41.15% |
| EPS Basic | 55.38% | 23.47% | 35.03% | 33.09% | 41.00% |
| Normalized Basic EPS | 62.52% | 28.66% | 31.52% | 24.96% | 34.28% |
| EPS Diluted | 54.39% | 23.13% | 34.25% | 32.36% | 40.87% |
| Normalized Diluted EPS | 62.33% | 28.66% | 31.52% | 24.96% | 34.28% |
| Average Basic Shares Outstanding | 17.93% | 21.64% | 22.42% | 19.88% | 14.56% |
| Average Diluted Shares Outstanding | 19.64% | 21.64% | 22.42% | 19.88% | 14.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.18% | -0.09% | -0.28% | -0.27% | -0.55% |